183 related articles for article (PubMed ID: 11704834)
1. Malignant transformation of primary chicken spleen cells by human transcription factor c-Rel.
Gilmore TD; Cormier C; Jean-Jacques J; Gapuzan ME
Oncogene; 2001 Oct; 20(48):7098-103. PubMed ID: 11704834
[TBL] [Abstract][Full Text] [Related]
2. Mutations of tumor necrosis factor alpha-responsive serine residues within the C-terminal transactivation domain of human transcription factor REL enhance its in vitro transforming ability.
Starczynowski DT; Reynolds JG; Gilmore TD
Oncogene; 2005 Nov; 24(49):7355-68. PubMed ID: 16027730
[TBL] [Abstract][Full Text] [Related]
3. Characterization of a human REL-estrogen receptor fusion protein with a reverse conditional transforming activity in chicken spleen cells.
Kalaitzidis D; Ok J; Sulak L; Starczynowski DT; Gilmore TD
Oncogene; 2004 Sep; 23(45):7580-7. PubMed ID: 15326488
[TBL] [Abstract][Full Text] [Related]
4. Divergent C-terminal transactivation domains of Rel/NF-kappa B proteins are critical determinants of their oncogenic potential in lymphocytes.
Fan Y; Rayet B; Gélinas C
Oncogene; 2004 Feb; 23(5):1030-42. PubMed ID: 14647412
[TBL] [Abstract][Full Text] [Related]
5. The c-Rel transcription factor and B-cell proliferation: a deal with the devil.
Gilmore TD; Kalaitzidis D; Liang MC; Starczynowski DT
Oncogene; 2004 Mar; 23(13):2275-86. PubMed ID: 14755244
[TBL] [Abstract][Full Text] [Related]
6. The v-rel oncogene promotes malignant T-cell leukemia/lymphoma in transgenic mice.
Carrasco D; Rizzo CA; Dorfman K; Bravo R
EMBO J; 1996 Jul; 15(14):3640-50. PubMed ID: 8670867
[TBL] [Abstract][Full Text] [Related]
7. Dual apoptotic effect of Xrel3 c-Rel/NF-kappaB homolog in human cervical cancer cells.
Shehata M; Shehata M; Shehata F; Pater A
Cell Biol Int; 2004; 28(12):895-904. PubMed ID: 15566959
[TBL] [Abstract][Full Text] [Related]
8. Differential roles of RelA (p65) and c-Rel subunits of nuclear factor kappa B in tumor necrosis factor-related apoptosis-inducing ligand signaling.
Chen X; Kandasamy K; Srivastava RK
Cancer Res; 2003 Mar; 63(5):1059-66. PubMed ID: 12615723
[TBL] [Abstract][Full Text] [Related]
9. Mutation of an IKK phosphorylation site within the transactivation domain of REL in two patients with B-cell lymphoma enhances REL's in vitro transforming activity.
Starczynowski DT; Trautmann H; Pott C; Harder L; Arnold N; Africa JA; Leeman JR; Siebert R; Gilmore TD
Oncogene; 2007 Apr; 26(19):2685-94. PubMed ID: 17072339
[TBL] [Abstract][Full Text] [Related]
10. An optimal range of transcription potency is necessary for efficient cell transformation by c-Rel to ensure optimal nuclear localization and gene-specific activation.
Fan Y; Gélinas C
Oncogene; 2007 Jun; 26(27):4038-43. PubMed ID: 17173064
[TBL] [Abstract][Full Text] [Related]
11. Identification of v-Rel oncogene-induced inhibitor of apoptosis by differential display.
You M; Bose HR
Methods; 1998 Dec; 16(4):373-85. PubMed ID: 10049645
[TBL] [Abstract][Full Text] [Related]
12. Bcl-2 and CrmA have different effects on transformation, apoptosis and the stability of I kappa B-alpha in chicken spleen cells transformed by temperature-sensitive v-Rel oncoproteins.
White DW; Gilmore TD
Oncogene; 1996 Sep; 13(5):891-9. PubMed ID: 8806678
[TBL] [Abstract][Full Text] [Related]
13. Aberrant rel/nfkb genes and activity in human cancer.
Rayet B; Gélinas C
Oncogene; 1999 Nov; 18(49):6938-47. PubMed ID: 10602468
[TBL] [Abstract][Full Text] [Related]
14. [The Rel/NF-kappa B transcription factors and their biological functions].
Kankova K; Vojtesek B; Valík D
Cas Lek Cesk; 2001 Mar; 140(6):163-7. PubMed ID: 11347205
[TBL] [Abstract][Full Text] [Related]
15. The nuclear factor kappaB subunits RelA/p65 and c-Rel potentiate but are not required for Ras-induced cellular transformation.
Hanson JL; Hawke NA; Kashatus D; Baldwin AS
Cancer Res; 2004 Oct; 64(20):7248-55. PubMed ID: 15492243
[TBL] [Abstract][Full Text] [Related]
16. Deletion of either C-terminal transactivation subdomain enhances the in vitro transforming activity of human transcription factor REL in chicken spleen cells.
Starczynowski DT; Reynolds JG; Gilmore TD
Oncogene; 2003 Oct; 22(44):6928-36. PubMed ID: 14534540
[TBL] [Abstract][Full Text] [Related]
17. Methods for assessing the in vitro transforming activity of NF-κB transcription factor c-Rel and related proteins.
Gilmore TD; Gélinas C
Methods Mol Biol; 2015; 1280():427-46. PubMed ID: 25736765
[TBL] [Abstract][Full Text] [Related]
18. v-Rel prevents apoptosis in transformed lymphoid cells and blocks TNFalpha-induced cell death.
Zong WX; Farrell M; Bash J; Gélinas C
Oncogene; 1997 Aug; 15(8):971-80. PubMed ID: 9285692
[TBL] [Abstract][Full Text] [Related]
19. NF-kappaB inducible genes BCL-X and cyclin E promote immature B-cell proliferation and survival.
Feng B; Cheng S; Hsia CY; King LB; Monroe JG; Liou HC
Cell Immunol; 2004; 232(1-2):9-20. PubMed ID: 15922711
[TBL] [Abstract][Full Text] [Related]
20. The v-Rel oncoprotein complexes with new Rel- and RelA-related proteins in transformed cells.
Xu X; Gélinas C
Virology; 1995 Mar; 207(2):362-8. PubMed ID: 7886940
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]